Insiders Just Sold Shares of These Healthcare Companies: SYK, ISRG, ZMH, DGX, WPI, GILD, HUM

Wall St. Watchdog reveals information about insiders who are bearish on these stocks in the Healthcare sector for the week ending December 2nd, 2011.

  • Ronda E Stryker who is Director at Stryker Corp. (NYSE:SYK), sold 9,000 shares on Nov 28 at $46.98 per share for a total value of $422,787. The shares recently traded at $49.09, up $2.13, or 4.54% since the insider sale. About the company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Get the most recent company news and stock data here >>
  • Salvatore Brogna who is SVP Product Development at Intuitive Surgical, Inc. (NASDAQ:ISRG), sold 21,073 shares on Dec 01 at $424.67 per share for a total value of $8,949,071. The shares recently traded at $436.43, up $0.84, or 0.19% since the insider sale. About the company: Intuitive Surgical, Inc. design, manufactures and markets surgical systems. The Company’s surgical system controls Intuitive Surgical endoscopic instruments, including rigid endoscopes, blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pickups, needle holders, endoscopic retractors, electrocautery, ultrasonic cutters, and accessories during surgical procedures. Get the most recent company news and stock data here >>
  • David C Dvorak who is President and CEO at Zimmer Holdings, Inc. (NYSE:ZMH), sold 27,044 shares on Dec 01 at $51.25 per share for a total value of $1,386,116. The shares recently traded at $49.61, down $1.25, or 2.46% since the insider sale. About the company: Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Zimmer markets its products in the United States and other countries around the world. Get the most recent company news and stock data here >>
  • Robert Hagemann who is SVP & Chief Financial Officer at Quest Diagnostics Inc. (NYSE:DGX), sold 4,150 shares on Dec 01 at $58.15 per share for a total value of $241,317. The shares recently traded at $57.67, down $0.1, or 0.17% since the insider sale. About the company: Quest Diagnostics Incorporated provides diagnostic testing, information, and services. The Company operates a national network of full-service laboratories, rapid response laboratories, and patient service centers. Quest Diagnostics provides esoteric testing, routine medical testing, drugs of abuse testing, and non-hospital-based anatomicpathology testing. Get the most recent company news and stock data here >>
  • Surya N Mohapatra who is Chairman, President & CEO at Quest Diagnostics Inc. (NYSE:DGX), sold 20,556 shares on Dec 01 at $57.95 per share for a total value of $1,191,187. The shares recently traded at $57.67, down $0.1, or 0.17% since the insider sale. About the company: Quest Diagnostics Incorporated provides diagnostic testing, information, and services. The Company operates a national network of full-service laboratories, rapid response laboratories, and patient service centers. Quest Diagnostics provides esoteric testing, routine medical testing, drugs of abuse testing, and non-hospital-based anatomicpathology testing. Get the most recent company news and stock data here >>
  • Michael J Fedida who is Director at Watson Pharmaceuticals Inc. (NYSE:WPI), sold 2,000 shares on Dec 02 at $63.32 per share for a total value of $126,640. The shares recently traded at $63.26, up $0.4, or 0.64% since the insider sale. About the company: Watson Pharmaceuticals, Inc. develops, manufactures, and sells generic and brand name pharmaceutical products. The Company’s core focus is specialty products, nephrology, urology, and generic products. Get the most recent company news and stock data here >>
  • John C Martin who is Chairman and CEO at Gilead Sciences Inc. (NASDAQ:GILD), sold 1,300 shares on Dec 02 at $40.00 per share for a total value of $52,000. The shares recently traded at $40.15, up $0.75, or 1.9% since the insider sale. About the company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions. Get the most recent company news and stock data here >>
  • Heidi S Margulis who is Senior V.P. – Public Affairs at Humana Inc. (NYSE:HUM), sold 11,362 shares on Dec 02 at $89.32 per share for a total value of $1,014,857. The shares recently traded at $86.87, down $2.24, or 2.51% since the insider sale. About the company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals. Get the most recent company news and stock data here >>
  • Jeffery A Mccaulley who is Pres – Zimmer Reconstructive at Zimmer Holdings, Inc. (NYSE:ZMH), sold 1,761 shares on Dec 02 at $51.47 per share for a total value of $90,643. The shares recently traded at $49.61, up $0.69, or 1.41% since the insider sale. About the company: Zimmer Holdings, Inc. designs, develops, manufactures, and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Zimmer markets its products in the United States and other countries around the world. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from publicly available SEC filings. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>